HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Geoffrey Oxnard Selected Research

Geoffrey Oxnard Research Topics

Disease

3Neoplasms (Cancer)
01/2023 - 08/2015
2Lung Neoplasms (Lung Cancer)
01/2020 - 08/2015
1Urinary Bladder Neoplasms (Bladder Cancer)
01/2023
1Breast Neoplasms (Breast Cancer)
01/2023
1Adenocarcinoma
01/2022
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2020
1Disease Progression
01/2020
1Acute Kidney Injury (Acute Renal Failure)
01/2020
1Adenocarcinoma of Lung
08/2015

Drug/Important Bio-Agent (IBA)

1Poly(ADP-ribose) Polymerase InhibitorsIBA
01/2023
1Circulating Tumor DNAIBA
01/2023
1ErbB Receptors (EGF Receptor)IBA
01/2023
1atezolizumabIBA
01/2023
1Trastuzumab (Herceptin)FDA Link
01/2022
1human ERBB2 proteinIBA
01/2022
1Biomarkers (Surrogate Marker)IBA
01/2022
11- (1- (imidazo(1,2- a)pyridin- 6- yl)ethyl)- 6- (1- methyl- 1H- pyrazol- 4- yl)- 1H- (1,2,3)triazolo(4,5- b)pyrazineIBA
01/2020
1osimertinibIBA
01/2020
1Tyrosine Kinase InhibitorsIBA
01/2020
1Cytokine Receptors (Cytokine Receptor)IBA
08/2015
1Amino AcidsFDA Link
08/2015
1Immune Checkpoint InhibitorsIBA
08/2015

Therapy/Procedure

2Therapeutics
01/2022 - 08/2015